A pharma giant’s decision to withhold new drugs from Thailand will only hurt patients, says Apoorva Mandavilli.

Is there ever a good enough reason to deny life-saving medicines to an entire country’s citizens?

I say no. But it seems a pharmaceutical giant begs to differ.

Read the column here.

A pharma giant’s decision to withhold new drugs from Thailand will only hurt patients, says Apoorva Mandavilli.

Is there ever a good enough reason to deny life-saving medicines to an entire country’s citizens?

I say no. But it seems a pharmaceutical giant begs to differ.

Read the column here.